Welldoc develops technology solutions to support chronic disease management. They work with leaders across the healthcare, life science, and medical device industries to ensure the solutions they develop scale and integrate into their existing workflows and systems. The Welldoc platform offers support for multiple chronic conditions, ecosystem solutions, and artificial intelligence.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Renovar engages in the discovery and development of diagnostic tests based on a portfolio of protein biomarkers for kidney disease and transplant monitoring. It provides a portfolio of protein biomarkers that indicate kidney injury using its urinary immunoassay platform; and CFSE Flow Kit that is used for tracking eight generations of cell proliferation in-vivo and in-vitro for mouse and human cells by flow cytometry. The company also offers custom assays and study services to support research activities, including biomarker selection and assay panel development, study design, data analysis, and samples testing. Renovar, Inc. was founded in 1999 and is headquartered in Appleton, Wisconsin.

Founded in 2002, Terradex applies information technology to increase the reliability of cleanup remedies reliant on institutional or engineering controls. Institutional controls are an integral part of health and environmental protection at many contaminated sites. Because cleanup technology cannot always remove contamination to safe levels, institutional controls are used to convey limitations on site use and activity to current and future stakeholders. Until Terradex, the reliability and enforceability of institutional controls was doubted. Tested by USEPA, Terradex is being applied nationwide at the site, city or state level.

Forschungsverbund Berlin conducts basic research in molecular pharmacology with the aim of identifying new bioactive molecules and characterizing their interactions with their biological targets in cells or organisms. The compounds are useful in basic biomedical research and may also be used to treat, prevent, or diagnose diseases. Also, they develop and use advanced technologies, which range from screening technologies to NMR-based methods to proteomics and in vivo models.

Beijing Shadong Biotech Co. Ltd. is a Chinese private company that develops therapeutics for treatment of cervical cancer.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, network, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery and other delivery services. It operates through the following segments: Mobility, Delivery and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered and, in certain markets, Delivery also includes offerings for grocery, alcohol and convenience store delivery and other goods. The Freight segment leverages proprietary technology, brand awareness, and experience revolutionizing industries to connect carriers with shippers on Uber’s platform, and gives carriers upfront, transparent pricing and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

Anhui Yangzi Air Conditioning Co., Ltd., established on 2000-12-09, The scope of business includes air conditioners,Air conditioner heat exchanger,Low temperature air source heat pump(cold)hot water unit,Central air-conditioning and other refrigeration equipment and components,heat exchanger,Refrigeration and air conditioning components,Artificial environment and high-efficiency energy-saving thermal equipment,Ventilation equipment and installations,Space environment and air handling equipment,Heating and temperature regulating equipment,Purification and filtration equipment,Research and development of humidification and dehumidification equipment,Production,Sales and technical consultation;Air conditioner matching electric control board,Home appliance matching control panel,Inverter,Electronic Component,electronic product,Computer Software and Hardware,Electronic Smart Controller,Intelligent control chip,Smart components,Electric adjustment equipment,Research and development of electric induction equipment,production and sales;Smart Appliances,smart furniture,smart home,Digital Electronics,stationery,sporting goods,handicraft design,research and development,production and sales;self-operated electronics,Electrical and Appliance Recycling;Electronic and electrical products,Electrical Equipment,Home appliances and their parts,Raw and auxiliary materials,Sales of metal materials;Household electrical appliances and raw materials,Technical development of components,technology transfer,Technical Advisory Services;Computer System Maintenance Services;software development;product design,model design,computer animation design,Packaging and decoration design;Electronic information and information processing technology;Big data operation;Application of cloud computing technology;Internet and IoT development and application;system integration;Online sales of self-produced products;Business Management Consulting;Business Consulting(finance,Insurance,securities,Except futures business);Corporate Image Planning;Conference and Exhibition Services;Large-scale event organization and planning services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

GEOSEC is a construction company that specializes in flooring consolidation and airport flooring services.

CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Robert Bosch GmbH engages in the development of the engineering and electronics sector. Its business sectors include; mobility solutions, industrial technology, consumer goods, and energy and building technology. The company was founded by Robert Bosch in 1886 and is headquartered in Gerlingen-Schillerhöhe, Germany.

CarePredict develops an AI-driven digital health platform for senior care. Its patented solution uses advanced remote sensing technologies, deep-machine learning, and user-friendly dashboards to continuously observe, learn, and trigger just-in-time care for seniors. Its sensing technologies permit the autonomous observation and collection of rich data sets about a user’s activities of daily living (ADLs). These rich data sets are then parsed within our deep learning systems to learn the behavior patterns of each senior and identify prescient changes in those patterns. The final predictions and alerts are then served up as actionable wellness insights to caregivers on our automated digital dashboards on browsers and smart devices.

EEGSmart provides an EEG-centered solution for bioinformatics sensors combined with artificial intelligence analysis. EEGSmart embraces multiple bio-electrical application patents and critical algorithms and autonomously develops software and hardware based BMI systems.